Back to search

Article

Estimation of ALU Repetitive Element in Plasma as a Cost-Effective Liquid Biopsy Tool for Disease Prognosis in Breast Cancer

2022-12-21

Abstract excerpt

<h4>Background: </h4> Liquid biopsy is widely recognised as an efficient diagnostic method in oncology for disease detection and monitoring. Though examination of circulating tumor cell (CTC) is mostly implemented for assessment of genomic aberrations, need of complex methodologies for their detection has impeded its acceptance in low resource settings. We evaluated the cell free DNA (cfDNA) as a liquid biopsy too...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
34c83eec-cb7f-56fb-9e06-2332bed29d84
DOI
10.20944/preprints202212.0400.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Estimation of ALU Repetitive Element in Plasma as a Cost-Effective Liquid Biopsy Tool for Disease Prognosis in Breast CancerDOI 10.20944/preprints202212.0400.v1
Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.Semantic proximity
Circulating cell-free DNA and its integrity as a prognostic marker for breast cancerSemantic proximity
The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.Semantic proximity
Cell‐free circulating tumour DNA as a liquid biopsy in breast cancerSemantic proximity
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?Semantic proximity
Liquid biopsy in early breast cancer. A preliminary reportSemantic proximity
Increased Blood Draws for Ultrasensitive ctDNA and CTCs Detection in Early Breast Cancer PatientsSemantic proximity
Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision MedicineSemantic proximity
Circulating Tumor DNA in Breast Cancer: Current and Future Applications.Semantic proximity
Plasma ALU-247, ALU-115, and cfDNA Integrity as Diagnostic and Prognostic Biomarkers for Breast CancerSemantic proximity
Non‐invasive detection of genome‐wide somatic copy number alterations by liquid biopsiesSemantic proximity
The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.Semantic proximity
Select a neighboring publication to make it the new centre.